Procter & Gamble Company (The) $PG Shares Acquired by Advocate Group LLC

Advocate Group LLC grew its position in Procter & Gamble Company (The) (NYSE:PG) by 0.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 51,761 shares of the company’s stock after purchasing an additional 125 shares during the period. Procter & Gamble makes up 1.5% of Advocate Group LLC’s holdings, making the stock its 24th largest position. Advocate Group LLC’s holdings in Procter & Gamble were worth $8,247,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Benjamin Edwards Inc. grew its holdings in Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after acquiring an additional 199,258 shares during the period. Capital Investment Advisory Services LLC grew its holdings in Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after acquiring an additional 4,562 shares during the period. World Investment Advisors grew its holdings in Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after acquiring an additional 2,886 shares during the period. Concurrent Investment Advisors LLC grew its holdings in Procter & Gamble by 26.4% during the first quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock worth $20,451,000 after acquiring an additional 25,059 shares during the period. Finally, Diversify Wealth Management LLC grew its holdings in Procter & Gamble by 10.3% during the first quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company’s stock worth $3,849,000 after acquiring an additional 2,210 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This trade represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on PG. JPMorgan Chase & Co. dropped their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a report on Friday. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday. Bank of America lowered their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, BNP Paribas Exane lowered their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.

Procter & Gamble Stock Performance

NYSE PG opened at $149.69 on Friday. The company has a market cap of $350.34 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. The stock’s 50 day simple moving average is $155.24 and its 200-day simple moving average is $159.48. Procter & Gamble Company has a 1-year low of $149.45 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.